Cytex is revolutionizing how organizations address the growing complexity of cybersecurity threats with a full-spectrum, AI-powered platform that integrates network operations, access management, third-party risk assessment, and compliance management into a single, cohesive solution. Its unified resilience approach saves time and costs while delivering persistent protection across devices, IT, IoT, OT, and networks.

New Frame AI is transforming video advertising with generative AI. Its platform enables businesses to produce high-quality video ads in minutes, drastically reducing production time and costs. By combining AI-driven video creation with advanced campaign optimization tools, it makes professional video advertising accessible and impactful for businesses of all sizes.

E62 Bio is a biotech startup specializing in the development of rapid diagnostic tests tailored to the needs of emerging markets.

EVCharz.com is a systems company transforming EV charging through innovative, universal green charging solutions featuring advanced hardware and software modules. As a leading supplier of EV charging systems on Amazon.in, it has recently signed an MOU with a major Asian battery manufacturer to develop universal DC charging systems for two- and three-wheeler EVs.

Encore Health is an AI-driven healthtech startup tackling the $336B insurance denial problem in the U.S. with its first product, DeCodeX. By leveraging AI, it helps hospitals successfully resolve insurance denials, streamlining the reimbursement process and reducing financial losses.

Fastagger specializes in developing platforms and orchestration tools to optimize machine learning models for edge devices, particularly in low-resource contexts. Their technology leverages advanced techniques such as model compression, secure local processing, and efficient cross-platform compatibility to ensure high-performance edge computing. Focused on addressing complex challenges, Fastagger currently emphasizes solutions within the TelcoAI space.

Based in Detroit and Lagos, Functional Fluidics is a global health technology company focused on improving red blood cell (RBC) health through the integration of Real-World Evidence (RWE), Clinical Trial Data (CTD), and advanced medical insights. It addresses the challenges of managing and treating RBC-related conditions, starting with Sickle Cell Disease (SCD), and targets underserved populations to enhance inclusion in clinical trials and address health disparities within an $81 billion market. By leveraging RBC health data, multi-omics, digital biomarkers, and diverse datasets, it provides comprehensive patient profiles that improve diagnostics and enable providers and pharma to deliver the right therapy to the right patient at the right time. Founded in 2014 by Patrick Hines, MD/PhD, who serves as CEO, it is driving innovation in RBC health.

GuideAI Health is revolutionizing cardiovascular diagnostics with an advanced AI platform designed to enhance radiologist expertise and improve patient outcomes. Built by clinicians and AI/ML experts in medical imaging, its algorithms rapidly detect millimeter-sized disease markers, reducing diagnostic errors. Its SaMD platform focuses on the early detection of Peripheral Vascular Disease (PVD), a chronic vascular condition affecting over 230 million people globally, who are at six times the risk of heart attack and stroke. Through proprietary AI models that convert raw imaging data into structured reports and seamlessly integrate into workflows, its first product, VascularAssist, delivers actionable insights to enhance surgical precision and guide personalized care.